Neurophos develops photonic AI processing technology that focuses on hardware solutions for accelerating artificial intelligence inference.
Neurophos has raised $110.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.
Neurophos's investors include Alumni Ventures, Gaingels, Bosch Ventures, Mana Ventures, DNX Ventures.
Neurophos is headquartered in Austin, United States.
Neurophos develops photonic AI processing technology that focuses on hardware solutions for accelerating artificial intelligence inference.
Neurophos is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neurophos — Funding & Investors." VCBacked, January 22, 2026, https://www.vcbacked.co/company/neurophos. Accessed July 21, 2026.
VCBacked. (2026). Neurophos — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/neurophos
{{cite web |title=Neurophos — Funding & Investors |url=https://www.vcbacked.co/company/neurophos |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated